Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer

Purpose. Circulating autoantibodies have been extensively investigated as possible markers for early diagnosis of cancer. The present study was carried out to investigate whether anti-LGALS3BP IgG autoantibodies could be classified as a biomarker for malignant tumors. Methods. An in-house developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassadonia, Antonino, Tinari, Nicola, Natoli, Clara, Yahalom, Galit, Iacobelli, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850626/
https://www.ncbi.nlm.nih.gov/pubmed/24347795
http://dx.doi.org/10.1155/2013/214595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850626/
https://www.ncbi.nlm.nih.gov/pubmed/24347795
http://dx.doi.org/10.1155/2013/214595

Ejemplares similares